Ozaki Yukio, Katagiri Yuki, Onuma Yoshinobu, Amano Tetsuya, Muramatsu Takashi, Kozuma Ken, Otsuji Satoru, Ueno Takafumi, Shiode Nobuo, Kawai Kazuya, Tanaka Nobuhiro, Ueda Kinzo, Akasaka Takashi, Hanaoka Keiichi Igarashi, Uemura Shiro, Oda Hirotaka, Katahira Yoshiaki, Kadota Kazushige, Kyo Eisho, Sato Katsuhiko, Sato Tadaya, Shite Junya, Nakao Koichi, Nishino Masami, Hikichi Yutaka, Honye Junko, Matsubara Tetsuo, Mizuno Sumio, Muramatsu Toshiya, Inohara Taku, Kohsaka Shun, Michishita Ichiro, Yokoi Hiroyoshi, Serruys Patrick W, Ikari Yuji, Nakamura Masato
Department of Cardiology, Fujita Health University School of Medicine, Toyoake, Japan.
Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Cardiovasc Interv Ther. 2018 Apr;33(2):178-203. doi: 10.1007/s12928-018-0516-y. Epub 2018 Mar 29.
While primary percutaneous coronary intervention (PCI) has significantly contributed to improve the mortality in patients with ST segment elevation myocardial infarction even in cardiogenic shock, primary PCI is a standard of care in most of Japanese institutions. Whereas there are high numbers of available facilities providing primary PCI in Japan, there are no clear guidelines focusing on procedural aspect of the standardized care. Whilst updated guidelines for the management of acute myocardial infarction were recently published by European Society of Cardiology, the following major changes are indicated; (1) radial access and drug-eluting stent over bare metal stent were recommended as Class I indication, and (2) complete revascularization before hospital discharge (either immediate or staged) is now considered as Class IIa recommendation. Although the primary PCI is consistently recommended in recent and previous guidelines, the device lag from Europe, the frequent usage of coronary imaging modalities in Japan, and the difference in available medical therapy or mechanical support may prevent direct application of European guidelines to Japanese population. The Task Force on Primary Percutaneous Coronary Intervention of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) has now proposed the expert consensus document for the management of acute myocardial infarction focusing on procedural aspect of primary PCI.
虽然直接经皮冠状动脉介入治疗(PCI)即使在心源性休克患者中也显著有助于提高ST段抬高型心肌梗死患者的生存率,但在日本的大多数医疗机构中,直接PCI是一种标准治疗方法。尽管日本有大量可提供直接PCI的机构,但尚无侧重于标准化治疗程序方面的明确指南。虽然欧洲心脏病学会最近发布了急性心肌梗死管理的更新指南,但指出了以下主要变化:(1)推荐桡动脉入路和药物洗脱支架优于裸金属支架作为I类适应证,(2)现在将出院前(即刻或分期)的完全血运重建视为IIa类推荐。尽管在最近和以前的指南中一直推荐直接PCI,但与欧洲的设备差距、日本冠状动脉成像方式的频繁使用以及可用药物治疗或机械支持的差异可能会阻碍将欧洲指南直接应用于日本人群。日本心血管介入和治疗学会(CVIT)直接经皮冠状动脉介入治疗特别工作组现在提出了一份关于急性心肌梗死管理的专家共识文件,重点关注直接PCI的程序方面。